SXC reported Q1 2026 results this morning and the split verdict defines the week's story: revenue of $455.1M beat the $418.1M estimate by a wide margin, yet EPS came in at a loss of $0.05 against a consensus of $0.07 profit. That gap between a top-line beat and a bottom-line miss is exactly the kind of print that keeps short sellers cautious without giving bulls much to celebrate either.
The one firm anchor management offered was a reaffirmation of its full-year adjusted EBITDA outlook of $230M–$250M. For a stock trading at $6.69 — well below the analyst mean target around $9.00 — that guidance hold matters. It removes the worst-case scenario from the table, at least for today. The stock edged up roughly 1.5% on the week heading into the print, though it dipped back 0.7% on Wednesday, and February's sharply negative earnings reaction (the stock fell 14.6% on the day and 28% over the five sessions following its last print) will be fresh in investors' minds.
The short interest picture tells a broadly unexciting story heading into the number. Bears have been unwinding steadily: SI as a share of free float dropped by more than half over the past month, from above 6% in mid-March to approximately 2.7% by April 29. The sharpest reversal came around April 9-10, when short positions were cut almost in half in a matter of days. Borrow conditions back this up — cost to borrow is running at just 0.54%, and the lending pool is wide open. Availability is extremely loose, meaning there is no squeeze dynamic in play here. The ORTEX short score of 31.1 sits in the bottom half of the universe, confirming this is not a stock where short sellers are pressing hard into earnings.
Options positioning adds a wrinkle. Call-side dominance is notable — the put/call ratio has fallen to 0.14, sitting close to its 52-week low of 0.10 and well below its 20-day average of 0.12. That skew toward calls rather than puts is mild in z-score terms (roughly half a standard deviation above the mean) but directionally consistent with traders leaning bullish into the print, or at least not paying up for downside protection. Peers pulled in the other direction this week: AMR fell 8.9% on the week, GSM dropped 3.6%, and MTUS lost 1.5%. Against that metals-sector headwind, SXC's flat-to-slightly-positive week looks comparatively resilient.
Insider buying from late February adds a layer of conviction behind the scenes. The CFO, a senior vice president, and an independent director all put personal money into the stock at prices between $5.53 and $5.84, accumulating roughly $157,000 in combined open-market purchases. Those buys came immediately after the February print that sent the stock tumbling. Net insider purchases across the 90-day window total around $660,000 — a small absolute sum for a company of this size, but the cluster of C-suite buying near the lows is a signal worth noting. At $6.69 today, the stock is still trading above those February purchase prices, though the February earnings hangover clearly lingers.
Street coverage is thin and the analyst data is over two months old, with the most recent action being B. Riley lowering its target to $9.00 from $10.00 in February — maintaining a Neutral rating. Benchmark continues to carry a Buy with a $13.00 target, which at current prices implies meaningful upside but reflects a vintage from late 2024. With analyst coverage limited and no fresh price-target revisions yet following today's print, the Street's formal take on SXC is essentially frozen until someone responds to this morning's results. The forward yield screens at roughly 6%, supported by today's concurrent cash dividend declaration — the first such announcement in some time and a positive signal on capital returns that investors may weigh against the earnings miss.
What to watch next is whether the revenue beat and guidance reaffirmation prompt any analyst updates — particularly from B. Riley, which has been the more active voice — and whether the stock can hold above the February insider-buying cluster around $5.80 if the EPS miss drives any fresh selling pressure in the sessions ahead.
See the live data behind this article on ORTEX.
Open SXC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
